# US 2018/0021209 A1 · Systems and methods for promotion of angiogenesis and adipogenesis in tissues through application of mechanical forces

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2018/0021209 A1
- Document ID: US20180021209A1
- Status: Published application
- Kind: A1
- Application number: 15/550,092
- Filed: 2016-02-17
- Published: 2018-01-25
- Earliest claimed: 2015-02-17
- Assignees: The Brigham and Women's Hospital, Inc.
- Applicants: Brigham and Women's Hospital, Inc.
- Inventors: Dennis Paul Orgill; Luca Lancerotto; Giorgio Giatsidis
- Web page: https://patentgrep.com/patent/US20180021209A1

## CPC

- A61H 9/0057: {Suction (suction kneading A61H7/008)}
- A61H 2201/5061: Force sensors
- A61H 2201/5071: Pressure sensors
- A61H 2201/5092: Optical sensor
- A61H 2230/206: used as a control parameter for the apparatus
- A61H 2230/208: used as a control parameter for the apparatus
- A61H 2230/505: used as a control parameter for the apparatus
- A61H: PHYSICAL THERAPY APPARATUS, e.g. DEVICES FOR LOCATING OR STIMULATING REFLEX POINTS IN THE BODY; ARTIFICIAL RESPIRATION; MASSAGE; BATHING DEVICES FOR SPECIAL THERAPEUTIC OR HYGIENIC PURPOSES OR SPECIFIC PARTS OF THE BODY (electrotherapy, magnetotherapy, radiation therapy or ultrasound therapy A61N)

## Abstract

A system and method for promoting angiogenesis and adipogenesis in soft tissue using a tissue enlargement apparatus. The tissue enlargement apparatus includes an interface configured for affixation to the soft tissue. A force generating device is coupled to the interface by a connecting tube for applying mechanical forces to the soft tissue. A processor is coupled to the force generating device and is configured to apply intermittent cyclical patterns of the mechanical forces to the soft tissue to promote angiogenesis and adipogenesis in soft tissue. The intermittent cyclical patterns are based on at least one of duration, frequency, and intensity of the mechanical forces.

## Claims

### Claim 1

A tissue enlargement apparatus for promoting angiogenesis and adipogenesis in soft tissue, the tissue enlargement apparatus comprising:
an interface configured for affixation to the soft tissue;
a force generating device coupled to the interface by a connecting tube for applying mechanical forces to the soft tissue;
a processor coupled to the force generating device and configured to apply intermittent cyclical patterns of the mechanical forces to the soft tissue to promote angiogenesis and adipogenesis in soft tissue that includes predetermined off-suction or reduced-suction periods and on-suction periods designed to extend over predetermined duration or number of sessions; and
wherein the intermittent cyclical patterns are based on at least one of duration, frequency, and intensity of the mechanical forces and include on-suction periods of between about 10 minutes and about 4 hours and off-suction or reduced-suction periods of between about 10 minutes and about 24 hours.

### Claim 2 (depends on 1)

The tissue enlargement apparatus of claim 1, wherein the interface is characterized by at least one a concave-shaped, a dome-shaped, a cup-shaped, and a sponge-shaped structure.

### Claim 3 (depends on 2)

The tissue enlargement apparatus of claim 2, wherein the sponge-shaped structure interface includes a plurality of pores positioned thereon to match morphological characteristics of the soft tissue based on finite element modeling carried out by the processor to predict mechanical response of the soft tissue.

### Claim 4 (depends on 1)

The tissue enlargement apparatus of claim 1, wherein the interface is constructed from at least one of a polymeric and metallic material.

### Claim 5 (depends on 1)

The tissue enlargement apparatus of claim 1, wherein the mechanical forces applied to the soft tissue by the force generating device are suction forces between about 10 mmHg and about 125 mmHg.

### Claim 6 (depends on 1)

The tissue enlargement apparatus of claim 1, further comprising at least one of a pressure sensor, a biosensor, and a piezoelectric gauge for monitoring a micro-environment of the soft tissue.

### Claim 7 (depends on 6)

The tissue enlargement apparatus of claim 6, wherein the piezoelectric gauge is configured to measure at least one of temperature of the soft tissue, perfusion of the soft tissue, pO2 of the soft tissue, and pCO2 of the soft tissue.

### Claim 8 (depends on 1)

The tissue enlargement apparatus of claim 1, wherein the interface is affixed to the soft tissue using at least one of flexible laces and adhesive dressings to seal the interface to the soft tissue.

### Claim 9 (depends on 1)

The tissue enlargement apparatus of claim 1, further comprising a drug release system controlled and monitored by the processor and configured to release drugs over preprogrammed times to the soft tissue.

### Claim 10 (depends on 1)

The tissue enlargement apparatus of claim 1, wherein the processor is configured to apply at least one of finite element analysis and finite element modeling to analyze how the mechanical forces are distributed on the soft tissue based on mechanical properties of the soft tissue to exploit a mitogenic pathway for improved angiogenesis and adipogenesis.

### Claim 11 (depends on 1)

The tissue enlargement apparatus of claim 1, wherein the intermittent cyclical patterns of suction are based on at least one of a ratio between the off-suction or reduced-suction periods and on-suction periods varying between 1 hour/30 minutes and 4 hours/60 minutes, a number of daily stimulations between 3 and 6, a total number of hours of stimulation daily being less than 6, an overall duration of treatment between 5 and 18 days, a pattern including 6 daily stimulations of 30 minutes each, followed by 1 hour breaks each for 5-9 days of treatment to induce angiogenesis, and stimulations patterns carried out with daily to every second day frequency to induce adipogenesis.

### Claim 12

A method for promoting angiogenesis and adipogenesis in soft tissue, the method comprising the steps of:
a) affixing an interface to the soft tissue;
b) applying mechanical forces to the soft tissue through the interface using a force generating device coupled thereto;
c) applying intermittent cyclical patterns of the mechanical forces to the soft tissue;
d) monitoring a micro-environment of the soft tissue to determine whether the intermittent cyclical patterns of the mechanical forces are selected for promoting angiogenesis and adipogenesis in the soft tissue;
e) analyzing how the mechanical forces are distributed on the soft tissue when the intermittent cyclical patterns are below a predetermined efficiency;
f) adjusting at least one of the mechanical forces and the intermittent cyclical patterns to raise the mechanical forces distributed on the soft tissue above the predetermined threshold.

### Claim 13 (depends on 12)

The method of claim 12, wherein the interface is characterized by at least one a concave-shaped, a dome-shaped, a cup-shaped, and a sponge-shaped structure.

### Claim 14 (depends on 13)

The method of claim 13, further comprising the step of matching morphological characteristics of the soft tissue based on modeling to predict a mechanical response of the soft tissue by providing a plurality of pores on the sponge-shaped structure interface.

### Claim 15 (depends on 12)

The method of claim 12, wherein applying the mechanical forces to the soft tissue by the force generating device includes providing suction forces between about 10 mmHg and about 125 mmHg to the soft tissue.

### Claim 16 (depends on 12)

The method of claim 12, further comprising the step of monitoring a micro-environment of the soft tissue using at least one of a pressure sensor, a biosensor, and a piezoelectric gauge.

### Claim 17 (depends on 16)

The method of claim 16, further comprising the step of measuring at least one of temperature of the soft tissue, perfusion of the soft tissue, pO2 of the soft tissue, and pCO2 of the soft tissue using the piezoelectric gauge.

### Claim 18 (depends on 12)

The method of claim 12, wherein affixing the interface to the soft tissue includes using at least one of flexible laces and adhesive dressings to seal the interface to the soft tissue.

### Claim 19 (depends on 12)

The method of claim 12, further comprising the step of implementing a drug release system controlled and monitored by a processor and configured to release drugs over preprogrammed times to the soft tissue.

### Claim 20 (depends on 12)

The method of claim 12, wherein the intermittent cyclical patterns of suction are based on at least one of a ratio between off suction and on suction varying between 1 hour/30 minutes and 4 hours/60 minutes, a number of daily stimulations between 3 and 6, a total number of hours of stimulation daily being less than 6, an overall duration of treatment between 5 and 18 days, a pattern including 6 daily stimulations of 30 minutes each, followed by 1 hour breaks each for 5-9 days of treatment to induce angiogenesis, and stimulations patterns carried out with daily to every second day frequency to induce adipogenesis.
